Lineage Cell Therapeutics LCTX
NYSE LCTX
$0.95 -0.01 (-1.04%)
At close: Sep 30, 2026 · 4:00 PM EDT

Lineage Cell Therapeutics (LCTX) Preferred Dividend Payments (2014 - 2015)

Updated

Lineage Cell Therapeutics' Preferred Dividend Payments came in at -$830,000 for Q4 2015, compared with $53,000 a year earlier.

Analysis

Lineage Cell Therapeutics (LCTX) Preferred Dividend Payments (2014 - 2015) Analysis & Trends

For FY2015, Lineage Cell Therapeutics' Preferred Dividend Payments was -$415,000.

  • Going back by year, Preferred Dividend Payments was $87,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Pref Dividends (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn -
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn -
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn -
10 Lineage Cell Therapeutics 240.26 Mn 38.67 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2015 -830,000.00
Sep 30, 2015 363,000.00
Jun 30, 2015 52,000.00
Dec 31, 2014 53,000.00
Sep 30, 2014 34,000.00
Jun 30, 2014 34,000.00
API Access

Lineage Cell Therapeutics Preferred Dividend Payments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-dividend-payments&ticker=LCTX&period=max&api_key=YOUR_API_KEY